T1D is characterized by inadequate endogenous insulin production [48], resulting in persistent hyperglycemia (i.e., high blood glucose/sugar levels) and necessitating lifelong exogenous insulin administration to counter this effect [51]. The gene discussed is INS; the disease is type 1 diabetes mellitus.